Multiple sclerosis: T-cell receptor expression in distinct brain regions

Brain

Volumn 130, Issue 11, 2007, Pages 2789-2799

  Junker, Andreas ^a   Ivanidze, Jana ^a,b   Malotka, Joachim ^b   Eiglmeier, Ingrid ^a   Lassmann, Hans ^c   Wekerle, Hartmut ^b   Meinl, Edgar ^a,b   Hohlfeld, Reinhard ^a,b   Dornmair, Klaus ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

^c Medical University of Vienna   (Austria)

Author keywords

Autoimmune T cells; Cytotoxic T cell response; Multiple sclerosis; Neuroimmunology; T cell receptor

Indexed keywords

NUCLEOTIDE; T LYMPHOCYTE RECEPTOR;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; AUTOPSY; BRAIN DAMAGE; BRAIN REGION; BRAIN TISSUE; CD8+ T LYMPHOCYTE; CELL ISOLATION; CHRONIC DISEASE; CONTROLLED STUDY; DEMYELINATING DISEASE; FEMALE; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LASER MICRODISSECTION; MALE; MOLECULAR CLONING; MULTIPLE SCLEROSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURGICAL ANATOMY; T LYMPHOCYTE; WHITE MATTER;

BRAIN; BRAIN CHEMISTRY; CD8-POSITIVE T-LYMPHOCYTES; CLONE CELLS; GENE REARRANGEMENT, BETA-CHAIN T-CELL ANTIGEN RECEPTOR; GENES, T-CELL RECEPTOR BETA; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIPLE SCLEROSIS; MUTATION; RECEPTOR-CD3 COMPLEX, ANTIGEN, T-CELL; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES;

EID: 35648948324     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awm214     Document Type: Article

References (55)

1. Acha-Orbea H, Mitchell DJ, Timmermann L, Wraith DC, Tasch GS, Waldor MK, et al. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell 1988; 54: 263-73.
2. Arden B, Clark SP, Kabelitz D, Mak TW. Human T-cell receptor variable gene segment families. IG 1995; 42: 455-500.
3. Arstila TP, Casrouge A, Baron V, Even J, Kanellopoulos J, Kourilsky P. A direct estimate of the human αβ T cell receptor diversity. Science 1999; 286: 958-61.
4. Babbe H, Roers A, Waisman A, Lassmann H, Goebels N, Hohlfeld R, et al. Clonal expansion of CD8+ T cells dominate the T cell infiltrate in active multiple sclerosis lesions shown by micromanipulation and single cell polymerase chain reaction. J Exp Med 2000; 192: 393-404.
5. Barnett MH, Prineas JW. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion (p NA). Ann Neurol 2004; 55: 458-68.
6. Bourdette DN, Edmonds E, Smith C, Bowen JD, Guttman CR, Nagy ZP, et al. A highly immunogenic trivalent T cell receptor peptide vaccine for multiple sclerosis. Mult Scler 2005; 11: 552-61.
7. Brück W, Brück Y, Diederich U, Piddlesden S. The membrane attack complex of complement mediates peripheral nervous system demyelination in vitro. Ann Neurol 1995; 90: 601-7.
8. Chluba J, Steeg C, Becker A, Wekerle H, Epplen JT. T cell receptor β chain usage in myelin basic protein-specific rat T lymphocytes. Eur J Immunol 1989; 19: 279-84.
9. Cohen IR. The cognitive paradigm and the immunological homunculus. Immunol Today 1992; 13: 490-4.
10. Davis MM, Bjorkman PJ. T-cell antigen receptor genes and T-cell recognition. Nature 1988; 334: 395-402.
11. Dornmair K, Goebels N, Weltzien HU, Wekerle H, Hohlfeld R. T-cell-mediated autoimmunity - novel techniques to characterize autoreactive T-cell receptors. Am J Pathol 2003; 163: 1215-26.
12. Friese MA, Fugger L. Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy? Brain 2005; 128: 1747-63.
13. Giegerich G, Pette M, Meinl E, Epplen JT, Wekerle H, Hinkkanen A. Diversity of T cell receptor α and β chain genes expressed by human T cells specific for similar myelin basic protein peptide/major histocompatibility complexes. Eur J Immunol 1992; 22: 753-8.
14. Goebels N, Michaelis D, Engelhardt M, Huber S, Berder A, Pongratz D, et al. Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis. J Clin Invest 1996; 97: 2905-10.
15. Gold R, Linington C, Lassmann H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 2006; 129: 1953-71.
16. Grunewald J, Janson CH, Wigzell H. Biased expression of individual T cell receptor V gene segments in CD4 and CD8 human peripheral blood T lymphocytes. Eur J Immunol 1991; 21: 819-22.
17. Hemmer B, Fleckenstein BT, Vergelli M, Jung G, McFarland HF, Martin R, et al. Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone. J Exp Med 1997; 185: 1651-9.
18. Hemmer B, Gran B, Zhao YD, Marques A, Pascal J, Tzou A, et al. Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease. Nature Med. 1999; 5: 1375-82.
19. Hickey WF. Basic principles of immunological surveillance of the normal central nervous system. Glia 2001; 36: 118-24.
20. Hofbauer M, Wiesener S, Babbe H, Roers A, Wekerle H, Dornmair K, et al. Clonal tracking of autoaggressive T cells in polymyositis by combining laser microdissection, single-cell PCR, and CDR3- spectra-type analysis. Proc Natl Acad Sci USA 2003; 100: 4090-5.
21. Hohlfeld R, Wekerle H. Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines. Proc Natl Acad Sci USA 2004; 101 (Suppl. 2): 14599-606.
22. Ji QY, Goverman J. Experimental autoimmune encephalomyeiltis mediated by CD8+ T cells. Ann NY Acad Sci 2007; 1103: 157-66.
23. Kivisäkk P, Mahad DJ, Callahan MK, Trebst C, Tucky B, Wei T, et al. Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. Proc Natl Acad Sci USA 2003; 100: 8389-94.
24. Kutzelnigg A, Lucchinetti CF, Stadelmann C, Brück W, Rauschka H, Bergmann M, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005; 128: 2705-12.
25. Laplaud DA, Berthelot L, Miqueu P, Bourcier K, Moynard S, Oudinet Y, et al. Serial blood T cell repertoire alterations in multiple sclerosis patients; correlation with clinical and MRI parameters. J Neuroimmunol 2006; 177: 151-60.
26. Laplaud DA, Ruiz C, Wiertlewski S, Brouard S, Berthelot L, Guillet M, et al. Blood T-cell receptor β chain transcriptome in multiple sclerosis. Characterization of the T cells with altered CDR3 length distribution. Brain 2004; 127: 981-95.
27. Lefranc M-P, Lefranc G. The T cell receptor facts book. London, UK: Academic Press; 2001.
28. Matsumoto Y, Yoon WK, Jee Y, Fujihara K, Misu T, Sato S, et al. Complementarity-determining region 3 spectratype analysis of the TCR repertoire in multiple sclerosis. J Immunol 2003; 170: 4846-53.
29. Meinl E, Weber F, Drexler K, Morelle C, Ott M, Saruhan-Direskeneli G, et al. Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis: complexity of response and dominance of nested epitopes due to recruitment of multiple T cell clones. J Clin Invest 1993; 92: 2633-43.
30. Monteiro J, Hingorani R, Peroglizzi R, Apatoff B, Gregersen PK. Oligoclonality of CD8+ T cells in multiple sclerosis. Autoimmunity 1996; 23: 127-38.
31. Muraro PA, Cassiani-Ingoni R, Chung K, Packer AN, Sospedra M, Martin R. Clonotypic analysis of cerebrospinal fluid T cells during disease exacerbation and remission in a patient with multiple sclerosis. J Neuroimmunol 2006; 171: 177-83.
32. Muraro PA, Vergelli M, Kalbus M, Banks D, Nagle JW, Tranquill LR, et al. Immunodominance of a low-affinity major histocompatibility complex binding myelin basic protein epitope (residues 111-129) in HLA-DR4 (B1*0401) subjects is associated with a restricted T cell receptor repertoire. J Clin Invest 1997; 100: 339-49.
33. Muraro PA, Wandinger KP, Bielekova B, Gran B, Marques A, Utz U, et al. Molecular tracking of antigen-specific T cell clones in neurological immune-mediated disorders. Brain 2003; 126: 20-31.
34. Neumann H, Medana IM, Bauer J, Lassmann H. Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci 2002; 25: 313-9.
35. Oksenberg JR, Panzara MA, Begovich AB, Mitchell D, Erlich HA, Murray RS, et al. Selection for T-cell receptor Vβ-Dβ-Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature 1993; 362: 68-70.
36. Oksenberg JR, Stuart S, Begovich AB, Bell RB, Erlich HA, Steinman L, et al. Limited heterogeneity of rearranged T-cell receptor Vα transcripts in brains of multiple sclerosis patients. Nature 1990; 345: 344-6.
37. Olerup O, Hillert J. HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens 1991; 38: 1-15.
38. Pannetier C, Even J, Kourilsky P. T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol Today 1995; 16: 176-81.
39. Puisieux I, Even J, Pannetier C, Jotereau F, Favrot M, Kourilsky P. Oligoclonality of tumor-infiltrating lymphocytes from human melanomas. J Immunol 1994; 153: 2807-18.
40. Rudolph MG, Stanfield RL, Wilson IA. How TCRs bind MHC, and coreceptotrs. Annu Rev Immunol 2006; 24: 419-66.
41. Seitz S, Schneider CK, Malotka J, Nong X, Engel AG, Wekerle H, et al. Reconstitution of paired T cell receptor α- and β-chains from microdissected single cells of human inflammatory tissues. Proc Natl Acad Sci USA 2006; 103: 12057-62.
42. Sercarz EE. Driver clones and determinant spreading. J Autoimmun 2000; 14: 275-7.
43. Skulina C, Schmidt S, Dornmair K, Babbe H, Roers A, Rajewsky K, et al. Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood. Proc Natl Acad Sci USA 2004; 101: 2428-33.
44. Steinman L. Myelin specific CD8 T cells in the pathogenesis of experimental allergic encephalomyelitis and multiple sclerosis. J Exp Med 2001; 194: F27-30.
45. Steinman L. Blocking adhesion molecules as therapy for multiple sclerosis: Natalizumab. Nat Rev Drug Discov 2005; 4: 510-518.
46. Turner SJ, Doherty PC, McClusky J, Rossjohn J. Structural determinants of T-cell receptor bias in immunity. Nat Rev Immunol 2006; 6: 883-94.
47. Van den Eynde B, Peeters O, De Backer O, Gaugler B, Lucas S, Boon T. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J Exp Med 1995; 182: 689-98.
48. Waisman A, Ruiz PJ, Hirschberg DL, Gelman A, Oksenberg JR, Brocke S, et al. Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity. Nat Med 1996; 2: 899-905.
49. Wekerle H, Linington C, Lassmann H, Meyermann R. Cellular immune reactivity within the CNS. Trends Neurosci 1986; 9: 271-7.
50. Wong FS, Karttunen J, Dumont C, Wen L, Visintin I, Pilip IM, et al. Identification of an MHC class I-restricted autoantigen in type I diabetes by screening an organ-specific cDNA library. Nat Med 1999; 5: 1026-31.
51. Wraith DC, McDevitt HO, Steinman L, Acha-Orbea H. T cell recognition as the target for immune intervention in autoimmune disease. Cell 1989; 57: 709-15.
52. Wucherpfennig KW, Newcombe J, Li H, Keddy C, Cuzner ML, Hafler DA. T cell receptor Vα-Vβ repertoire and cytokine gene expression in active multiple sclerosis lesions. J Exp Med 1992; 175: 993-1002.
53. Wucherpfennig KW, Ota K, Endo N, Seidman JG, Rosenzweig A, Weiner HJ, et al. Shared human T cell receptor Vβ usage to immunodominant regions of myelin basic protein. Science 1990; 248: 1016-9.
54. Wucherpfennig KW, Zhang J, Witek C, Matsui M, Modabber Y, Ota K, et al. Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide. J Immunol 1994; 152: 5581-92.
55. Zhang X-M, Heber-Katz E. T cell receptor sequences from encephalitogenic T cells in adult Lewis rats suggest an early ontogenic origin. J Immunol 1992; 148: 746-52.